These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage. Eandi M; Viano I; Di Nola F; Leone L; Genazzani E Eur J Clin Microbiol; 1983 Jun; 2(3):253-9. PubMed ID: 6224683 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys. Nakamura S; Kurobe N; Kashimoto S; Ohue T; Takase Y; Shimizu M Antimicrob Agents Chemother; 1983 Jul; 24(1):54-60. PubMed ID: 6226241 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of norfloxacin in renal failure. Fillastre JP; Hannedouche T; Leroy A; Humbert G J Antimicrob Chemother; 1984 Oct; 14(4):439. PubMed ID: 6238930 [No Abstract] [Full Text] [Related]
12. The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin. Nye K; Shi YG; Andrews JM; Ashby JP; Wise R J Antimicrob Chemother; 1989 Sep; 24(3):415-24. PubMed ID: 2808194 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tissue penetration of enoxacin. Wise R; Lockley R; Dent J; Webberly M Antimicrob Agents Chemother; 1984 Jul; 26(1):17-9. PubMed ID: 6591851 [TBL] [Abstract][Full Text] [Related]
14. The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin. Wise R; Lister D; McNulty CA; Griggs D; Andrews JM Infection; 1986; 14 Suppl 3():S196-202. PubMed ID: 3463542 [TBL] [Abstract][Full Text] [Related]